ArticleSerican journal of medicine2024
Acetate Metabolism in Urological Health and Disease.
Article in Serican journal of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endothelial CPT2 loss impairs fatty acid oxidation and promotes renal fibrosis.Life metabolism · 2026Article
- HOXB13-Mediated Lipid Metabolism Regulates Prostate Cancer Metastasis.Serican journal of medicine · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Acetate, the simplest short-chain fatty acid, serves key roles in urological health as both a nutrient and an endogenous molecule. It originates from gut microbial fermentation of dietary fiber and is found in common foods like dairy products, pasta, coffee, and vinegar. Additionally, acetate is synthesized internally to support energy metabolism and cell signaling pathways. This review highlights recent advancements in understanding acetate's function as a signaling molecule in regulating cell fate and activity, with implications for urological health and disease treatment. The potential of acetate as a biomarker for urological health is examined, offering valuable insights that could enhance strategies for disease diagnosis, management, and therapeutic development. Furthermore, the review explores the application of non-invasive imaging techniques to monitor acetate metabolism for the diagnosis, staging, and management of urological cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.